Literature DB >> 7728799

Exercise capacity and prognosis in patients with chronic atrial fibrillation.

K Ueshima1, J Myers, P M Ribisl, C K Morris, T Kawaguchi, J Liu, V F Froelicher.   

Abstract

To evaluate the response of patients with chronic atrial fibrillation (AF) to exercise and to demonstrate if prognosis could be predicted, 200 male patients (64 +/- 1 years) with AF were identified retrospectively who underwent resting echocardiography and symptom-limited treadmill testing. They were classified by underlying disease into three subgroups: hypertension or no underlying disease (LONE; n = 102), ischemic heart disease (IHD; n = 45) and history of congestive heart failure or valvular disease (CHF-VD; n = 53). Maximal exercise capacities for LONE, IHD and CHF-VD were (mean +/- 1 SEM) 8.0 +/- 0.3, 6.4 +/- 0.4 and 6.0 +/- 0.3 metabolic equivalents, respectively (p < 0.01), and resting left ventricular ejection fractions were 61.7 +/- 1.6, 60.1 +/- 2.2 and 49.5 +/- 1.9%, respectively (p < 0.01). Stepwise multiple regression analysis demonstrated that, except for group classification (R2 = 0.13, p < 0.01), no clinical, exercise or morphologic variables could predict exercise capacity. After a mean 39.1-month follow-up (range 1-78), 17 of the 200 had died from cardiovascular causes. The rate of cardiac death using Kaplan-Meier survival analysis was significantly greater in CHF-VD patients (p < 0.01). However, Cox hazard function and Kaplan-Meier survival analysis demonstrated that neither echocardiographic measurements of cardiac size or function at rest, nor exercise or clinical variables were significant predictors of outcome. AF patients with a history of CHF and/or VD demonstrated a reduced exercise tolerance ad a worse prognosis than those without morphologic heart disease or those with IHD.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7728799     DOI: 10.1159/000176850

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  4 in total

1.  Health-related quality of life relative to clinical outcomes in patients with atrial fibrillation treated with ventricular rate stabilisation pacing.

Authors:  M A M Stofmeel; N M van Hemel; J C Kelder; R Yee; R E Labonté; M Taborsky; D E Grobbee
Journal:  Neth Heart J       Date:  2006-03       Impact factor: 2.380

2.  Atrial Fibrillation and Declining Physical Performance in Older Adults: The Health, Aging, and Body Composition Study.

Authors:  Jared W Magnani; Na Wang; Emelia J Benjamin; Melissa E Garcia; Douglas C Bauer; Javed Butler; Patrick T Ellinor; Stephen Kritchevsky; Gregory M Marcus; Anne Newman; Caroline L Phillips; Hiroyuki Sasai; Suzanne Satterfield; Lisa M Sullivan; Tamara B Harris
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-05

3.  Clinical significance of left atrial volume in clinical outcomes of heart transplant recipients.

Authors:  Saad Ahmad; Pradeep Gujja; Tehmina Naz; Jun Ying; Stephanie H Dunlap; Yukitaka Shizukuda
Journal:  J Cardiothorac Surg       Date:  2015-07-11       Impact factor: 1.637

4.  Short-term ECG recordings for heart rate assessment in patients with chronic atrial fibrillation.

Authors:  Michal Chudzik; Iwona Cygankiewicz; Artur Klimczak; Joanna Lewek; Karol Bartczak; Jerzy K Wranicz
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.